BioLife Solutions, Inc. (BLFS) Gross margin 2017–2025
BioLife Solutions, Inc. (BLFS) gross margin by fiscal year — reported gross profit divided by reported revenue.
64.6%FY2025 · since FY2017: 61.2% → 64.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 64.6% | -2.5 pp |
| FY2024 | 67.1% | +6.4 pp |
| FY2023 | 60.7% | — |
| FY2019 | 68.0% | -0.5 pp |
| FY2018 | 68.5% | +7.3 pp |
| FY2017 | 61.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More BLFS financial trends
BLFS RevenueBLFS Net incomeBLFS Net marginBLFS Gross profitBLFS Operating incomeBLFS Operating marginBLFS Operating cash flowBLFS Free cash flowBLFS Capital expendituresBLFS Return on equityBLFS Stock buybacksBLFS Dividends paidBLFS Total assetsBLFS Total liabilitiesBLFS Shareholders’ equityBLFS overview →